


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
GILD
Gilead Sciences
$122.60
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Outperform the market

Investors confidence is positive
GILD Price Performance
$120.4 (+1.83%)
$118.3 (+3.63%)
$117.98 (+3.92%)
$93.85 (+30.63%)
GILD has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk

GILD overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
GILD Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
GILD Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels
What is GILD current stock price?
What are GILD stock strengths?
What is GILD Risk Level?
What is GILD market cap and volume?
What is GILD current Stock IQ?
Should I buy GILD stock right now?
Is GILD a Strong Buy right now?
What does a 'Strong Buy' rating mean for GILD?
What does a 'Strong Sell' rating mean for GILD?
What factors influence GILD's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
GILD
Gilead Sciences
Current Price
$122.60
GILD Stock IQ
Stock Insights
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Outperform the market

Investors confidence is positive

GILD Price Performance
$120.4 (+1.83%)
$118.3 (+3.63%)
$117.98 (+3.92%)
$93.85 (+30.63%)
GILD Analysts Opinion
GILD Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
GILD Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
GILD Street Sentiment is extremely bullish and have positive views on the near-term outlook
GILD has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk

Average key support and resistance price levels
GILD Latest Analysis
Gilead Sciences Inc. (GILD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript.
Today
UBS and Citi Go ish on Gilead Sciences (GILD).
Today
UBS and Citi Go ish on Gilead Sciences (GILD). Gilead Sciences Inc. (NASDAQ:GILD) is one of the most undervalued blue chip stocks to buy now. On January 7 2026 reports highlighted that analysts are increasingly confident in Gilead Sciences Inc. (NASDAQ:GILD)s short- and medium-term outlook driven by optimism around the companys HIV franchise. On that day UBS analyst Michael Yee upgraded the stock from [….]
Today
Heres Why Gilead Sciences (GILD) is a Strong Momentum Stock. The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why you should take advantage.
Wed Jan 7, 2026
Gilead Sciences (GILD) Stock Declines While Market Improves: Some Information for Investors. Gilead Sciences (GILD) concluded the recent trading session at $118.3 signifying a -2.71% move from its prior days close.
Mon Jan 5, 2026
Gilead (GILD) Reaches Pricing Agreement with US Government to Lower Drug Costs. Gilead Sciences Inc. (NASDAQ:GILD) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 19 Gilead Sciences Inc. (NASDAQ:GILD) announced an agreement with the US government aimed at lowering drug costs for Americans. The move reinforces the companys long-standing focus on US-based innovation affordability and global health leadership. Under the [….]
Tue Dec 30, 2025
Is Gilead Sciences (GILD) An Affordable Healthcare Stocks to Invest In?. Gilead Sciences Inc. (NASDAQ:GILD) is one of the best affordable healthcare stocks to buy now. Gilead Sciences Inc. (NASDAQ:GILD) announced on December 22 that it has exercised its combined option to exclusively license Assembly Bios herpes simplex virus (HSV) helicase-primase inhibitor programs which include long-acting investigational candidates ABI-1179 and ABI-5366 for recurrent genital herpes. Management reported [R
Tue Dec 30, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
GILD Stock trends
GILD Stock performance
GILD Stock analysis
GILD investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.